Two distinct effects of cGMP on cytosolic Ca2+ concentration of rat pancreatic β-cells

Journal Pharmacological Sciences

Volumn 91, Issue 1, 2003, Pages 41-46

  Ishikawa, Tomohisa ^a   Kaneko, Yukiko ^a   Sugino, Fumi ^a   Nakayama, Koichi ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

Author keywords

Calcium; cGMP; Glucose; Islets of langerhans; NOC 7

Indexed keywords

1 HYDROXY 2 OXO 3 (N METHYL 3 AMINOPROPYL) 3 METHYL 1 TRIAZENE; 1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 4 AMINOPYRIDINE; 8 BROMO CYCLIC AMP; CALCIUM CHANNEL L TYPE; CALCIUM ION; CYCLIC GMP; GLUCOSE; GUANYLATE CYCLASE INHIBITOR; NICARDIPINE; NITRIC OXIDE DONOR; NOC 7; POTASSIUM CHANNEL; POTASSIUM ION; THAPSIGARGIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CALCIUM TRANSPORT; CELL ISOLATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOSOL; DRUG EFFECT; DRUG INHIBITION; DRUG MECHANISM; ENDOPLASMIC RETICULUM; INSULIN RELEASE; MALE; NONHUMAN; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL FUNCTION; RAT;

4-AMINOPYRIDINE; ANIMALS; CALCIUM; CYCLIC GMP; CYTOSOL; DIMETHYL SULFOXIDE; ENZYME INHIBITORS; GLUCOSE; HYDRAZINES; HYPOGLYCEMIC AGENTS; ISLETS OF LANGERHANS; NITRIC OXIDE; NITRIC OXIDE DONORS; OXADIAZOLES; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; QUINOXALINES; RATS; TOLBUTAMIDE;

EID: 0038054336     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.91.41     Document Type: Article

References (24)

1. Schmidt HH, Warner TD, Ishii K, Sheng H and Murad F: Insulin secretion from pancreatic B cells caused by L-arginine-derived nitrogen oxides. Science 255, 721-723 (1992)
2. Alm P, Ekstrom P, Henningsson R and Lundquist I: Morphological evidence for the existence of nitric oxide and carbon monoxide pathways in the rat islets of Langerhans: An immunocytochemical and confocal micoscopical study. Diabeteologia 42, 978-986 (1999)
3. Lajoix AD, Reggio H, Chardes T, Peraldi-Roux S, Tribillac F, Roye M, Dietz S, Broca C, Manteghetti M, Ribes G, Wollheim CB and Gross R: A neuronal isoform of nitric oxide synthase expressed in pancreatic β-cells controls insulin secretion. Diabetes 50, 1311-1323 (2001)
4. Ding Y and Rana RS: Nitric oxide does not initiate but potentiates glucose-induced insulin secretion in pancreatic β-cells. Biochem Biophens Res Commun 251, 699-703 (1998)
5. Laychock SG, Modica ME and Cavanaugh CT: L-arginine stimulates cyclic guanosine 3′,5′-monophosphate formation in rat islets of Langerhans and RINm5F insulinoma cells: Evidence for L-arginine: Nitric oxide synthase. Endocrinology 129, 3043-3052 (1991)
6. 2+ mobilization and increased secretion of incorporated 5-hydroxytrptamine in rat pancreatic β-cells. FEBS Lett 371, 99-104 (1995)
7. 2+ concentration in rat pancreatic β-cells. Life Sci 65, 1515-1522 (1999)
8. Panagiotidis G, Akesson B, Rydell EL and Lundquist I: Influence of nitric oxide synthase inhibition, nitric oxide and hydroperoxide on insulin release induced by various secretogogues. Br J Pharmacol 114, 289-296 (1995)
9. + channels through supression of phosphofructokinase activity and inhibits glucose-induced insulin release in pancreatic β cells. J Gen Physiol 104, 1079-1098 (1994)
10. + channels. Biochim Biophys Acta 1175, 293-301 (1993)
11. Cunningham JM, Mabley JG, Delaney CA and Green IC: The effect of nitric oxide donors on insulin secretion, cyclic GMP and cyclic AMP in rat islets of Langerhans and the insulin-secreting cell lines HIT-T15 and R15 and RINm5F. Mol Cell Endocrinol 102, 23-29 (1994)
12. Wollheim CB and Sharp GW: Regulation of insulin release by calcium. Physiol Rev 61, 914-973 (1981)
13. Karaki H, Ozaki H, Hori M, Mitsui-Saito M, Amano K, Harada K, Miyamoto S, Nakazawa H, Won KJ and Sato K: Calcium movements, distribution, and functions in smooth muscle.. Pharmacol Rev 49, 157-230 (1997)
14. 2+ in single pancreatic β-cells. Biochem Biophys Res Commun 150, 419-425 (1988)
15. Moncada S, Palmer RM and Higgs EA: Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmal Rev 43, 109-142 (1991)
16. Ignarro LJ, Buga GM, Wood KS, Byrns RE and Chaudhuri G: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84, 9265-9269 (1987)
17. 2+ signaling and the insulin secretory cascade in the pancreatic beta-cell. Jpn J Pharmacol 80, 191-197 (1999)
18. Voyles N, Gutman RA, Selawry H, Fink G, Penhos JC and Recant L: Interaction of various stimulators and inhibitors on insulin secretion in vitro. Horm Res 4, 65-73 (1973)
19. Laychock SG: Evidence for guanosine 3′,5′-monophosphate as a putative mediator of insulin secretion from isolated rat islets. Endocrinology 108, 1197-1205 (1981)
20. 2+ origin. J Physiol (Lond) 488, 13-24 (1995)
21. 2+ signalling: Problems and pitfalls. Trends Pharmacol Sci 19, 370-375 (1998)
22. 2+-ATPase. Proc Natl Acad Sci USA 87, 2466-2470 (1990)
23. 2+ concentration. J Biol Chem 273, 33501-33507 (1998)
24. Drews G: Endocrine pancreas. In Comprehensive Human Physiology, Edited by Greger R and Windhorst U, Vol. 2, pp 1345-1367, Springer, Berlin Heidelberg (1996)